Synergistic effects of co‐expression of the Th1 cytokines il‐2 and IFNγ on generation of murine tumor‐reactive cytotoxic cells

While the effect of cytokines on the generation of tumor‐reactive cytotoxic cells has been a topic of active investigation, the effect of physiological cytokine combinations has not been determined. We have investigated the effect of co‐expression of IL‐2 and IFN‐γ on the generation of cytotoxic cells against the murine line 1 tumor in vivo. These cytokines were selected because they are normally produced in concert by a subset of T‐helper cells called T‐helper 1 (Th1). We transfected the line 1 murine carcinoma with cDNA for IL‐2 and IFN‐γ, alone or combined. IFN‐γ alone does not elicit rejection of the transfectant, but IL‐2 increases the tumorigenic dose by 10,000‐fold above the parental cells. Co‐expression of IFN‐γ and IL‐2 increases this rejection to at least 100,000‐fold above parental line 1. Unlike IL‐2 transfectants, tumor cells expressing both IFN‐γ and IL‐2 can also elicit rejection of admixed parental tumor cells. Finally, the IFN‐γ/IL‐2 transfectants are more effective at generating memory cells that are cytolytic for the parental tumor. Our results show that synergistic interactions of Th1 cytokines can remarkably enhance the cytotoxic response to tumors. © 1995 Wiley‐Liss, Inc.

[1]  J. Frelinger,et al.  Transfection of Transforming Growth Factor-β Producing Tumor EMT6 with Interleukin‐2 Elicits Tumor Rejection and Tumor Reactive Cytotoxic T‐Lymphocytes , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[2]  M. Colombo,et al.  Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? , 1994, Immunology today.

[3]  P. Musiani,et al.  Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene , 1993 .

[4]  A. McAdam,et al.  Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. , 1993, Cancer research.

[5]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Venzon,et al.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.

[7]  J. Yewdell,et al.  Identification of human cancers deficient in antigen processing , 1993, The Journal of experimental medicine.

[8]  P. Leder,et al.  An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. , 1992, Science.

[9]  M. Schilham,et al.  Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 , 1991, Nature.

[10]  P. Frost,et al.  Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. , 1991, Cancer research.

[11]  J. Frelinger,et al.  Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection. , 1990, Cellular immunology.

[12]  S. Miyatake,et al.  Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Maraskovsky,et al.  IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. , 1989, Journal of immunology.

[14]  L. Harwell,et al.  Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Bahler,et al.  Enhanced immune recognition of H-2 antigen-deficient murine lung carcinoma cells following treatment with dimethyl sulfoxide. , 1985, Cancer research.

[16]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.

[17]  R. Coffman,et al.  Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.

[18]  T. Mosmann Cytokine secretion patterns and cross-regulation of T cell subsets , 1991, Immunologic research.

[19]  K. Cerosaletti,et al.  Class‐I MHC expression in the mouse lung carcinoma, line 1: A model for class‐I inducible tumors , 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.